Drug Type Small molecule drug |
Synonyms SY 201, SY-201, SY201 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 2 | United States | 25 Jul 2022 |
Phase 1/2 | 201 | (SY-201 Ophthalmic Solution 2.0%) | cwievigmdt(smrxgzzbit) = almrabedao njmgguqhqh (ltsdffuztw, 1.989) View more | - | 26 Nov 2024 | ||
(SY-201 Ophthalmic Solution 1.0%) | cwievigmdt(smrxgzzbit) = nnekfopmwd njmgguqhqh (ltsdffuztw, 2.642) View more |